Deferred Tax Assets
Non-Current AssetsEli Lilly Deferred Tax Assets increased by 11.1% to $9.96B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 24.5%, from $8.00B to $9.96B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets shows an upward trend with a 28.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests the company has more 'tax shields' to protect future earnings, while a valuation allowance against them would signal doubt about future profitability.
Detailed definition
An asset on the balance sheet that results from overpayment or advance payment of taxes, or from carryforwards of losses...
Peer comparison
Companies with significant R&D operations typically carry higher deferred tax assets due to government incentives for innovation.
deferred_tax_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.67B | $2.63B | $2.49B | $2.46B | $2.37B | $2.38B | $2.79B | $3.41B | $3.81B | $4.57B | $5.48B | $5.63B | $6.66B | $7.39B | $8.00B | $8.57B | $9.43B | $8.96B | $9.96B |
| QoQ Change | — | -1.8% | -5.2% | -1.0% | -3.8% | +0.5% | +17.1% | +22.0% | +11.7% | +20.2% | +19.7% | +2.9% | +18.1% | +11.1% | +8.2% | +7.2% | +10.0% | -4.9% | +11.1% |
| YoY Change | — | — | — | — | -11.3% | -9.2% | +12.2% | +38.2% | +60.5% | +91.9% | +96.1% | +65.4% | +74.9% | +61.6% | +46.1% | +52.2% | +41.7% | +21.2% | +24.5% |
Deferred Tax Assets at Other Companies
Frequently Asked Questions
- What is Eli Lilly's deferred tax assets?
- Eli Lilly (LLY) reported deferred tax assets of $9.96B in Q4 2025.
- How has Eli Lilly's deferred tax assets changed year-over-year?
- Eli Lilly's deferred tax assets increased by 24.5% year-over-year, from $8.00B to $9.96B.
- What is the long-term trend for Eli Lilly's deferred tax assets?
- Over 5 years (2020 to 2025), Eli Lilly's deferred tax assets has grown at a 28.6% compound annual growth rate (CAGR), from $2.83B to $9.96B.
- What does deferred tax assets mean?
- A tax overpayment or credit that the company can use to lower its tax bill in the future.